Cargando...
Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients
In vitro treatment of Nf2-deficient cells with epidermal growth factor receptor (EGFR) inhibitors can inhibit cellular proliferation. We retrospectively assessed the effect of erlotinib (150 mg daily) on eleven consecutive NF2 patients with progressive VS who were poor candidates for standard therap...
Gardado en:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2010
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4030413/ https://ncbi.nlm.nih.gov/pubmed/20736812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MAO.0b013e3181eb328a |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|